Pascale Quatresooz

Pascale Quatresooz

Auto-generated profile, based on publicly available information

Pascale Quatresooz

Department of Human Histology and Dermatopathology, University Hospital of Liège University (CHU), 4000 Liège, Belgium

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2006 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
PPP. Paquet
P. Paquet
SKSrini Kaveri
Srini Kaveri
EJE. Jacob
E. Jacob
JPJ. Pirson
J. Pirson
PQP. Quatresooz
P. Quatresooz
GPGérald Pierard
Gérald Pierard

12 June 2012 in Journal of Biomedicine and Biotechnology
Verified
Journal Article
Open access
PDF file
PQPascale Quatresooz
Pascale Quatresooz
THTrinh Hermanns-Lê
Trinh Hermanns-Lê
GPGérald Pierard
Gérald Pierard
PHPhilippe Humbert
Philippe Humbert
PDPhilippe Delvenne
Philippe Delvenne
CPClaudine Piérard-Franchimont
Claudine Piérard-Franchimont
Psoriasis is a chronic relapsing immunoinflammatory dermatosis that is commonly associated with systemic comorbidities. The pathogenic importance of interleukin (IL)-12 and IL-23 is beyond doubt, as well as the involvement of T helper cells (Th)1 and Th17 cells. There is upregulation of the p40 subunit shared by IL-12 and IL-23 and of the IL-23 p19 subunit, but not an increased expression of the IL-12 p35 subunit. This indicates that IL-23 appears more involved than IL-12 in the pathogenesis of psoriatic plaques. Ustekinumab is a fully human monoclonal antibody of the immunoglobulin (Ig) G1 class targeting the p40 subunit common to both IL-12 and IL-23, thus inhibiting both IL-12 and IL-23 receptor-mediated signalling. Ustekinumab is part of the recent biologic therapies active in psoriasis, autoimmune arthritides, and inflammatory bowel diseases.

1 July 2009 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
GBGéraldine Blaise
Géraldine Blaise
ANArjen F Nikkels
Arjen F Nikkels
PQPascale Quatresooz
Pascale Quatresooz
THT. Hermanns-Lê
T. Hermanns-Lê
GPGérald Pierard
Gérald Pierard

2 June 2023 in Morphologie
Verified
Journal Article
Closed access
LPL. Pesesse
L. Pesesse
BDB.O. Dozo
B.O. Dozo
PQP. Quatresooz
P. Quatresooz
AWA. Weatherspoon
A. Weatherspoon
SMS. Multon
S. Multon
VDV. Defaweux
V. Defaweux


27 March 2008 in Dermatology
Verified
Journal Article
Closed access
PDF file
PQP. Quatresooz
P. Quatresooz
CPC. Piérard-Franchimont
C. Piérard-Franchimont
GPGérald Pierard
Gérald Pierard
Background: In Westernized populations, the number of diagnosed cases of primary cutaneous cancers, particularly malignant melanomas and basal cell carcinomas (BCC), has been previously shown to fluctuate during specific periods of the year. Objective and Method: The aim of the present 6-year study was to explore the seasonality if any in skin cancer detection in Wallonia (south-east Belgium). Results: For both malignant melanomas and BCC late spring/early summer and mid-autumn were the periods of highest diagnosis prevalence irrespective of gender. The amplitude of this bimodal evolution remained within the range of 2 standard deviations around the monthly means. Similar seasonal variations were also found in non-neoplastic controls consisting of laboratory samplings of onychomycoses and non-infectious onychodystrophies. Conclusion: There is reason to believe that this timing and rhythm is unrelated to any specific cancer chronomics. Rather, the present findings suggest unspecific seasonality in diagnosing skin disorders including malignancies. A variable patient awareness of changing aspects of the skin according to seasons probably represents the major influence of the described space-time clustering of skin cancer diagnosis.